Showing posts with label pancreatic cancer. Show all posts
Showing posts with label pancreatic cancer. Show all posts

Friday, September 6, 2013

FDA Approves Abraxane for Pancreatic Cancer

ABRAXANE® (generic name: nab-paclitaxel) was approved by the FDA as first-line therapy for the metastatic adenocarcinoma of the pancreas when used in combination with gemcitabine. The approval of ABRAXANE is a major development in pancreatic cancer care and is expected to replace gemcitabine alone as a new standard of care for pancreatic cancer. 

Monday, December 19, 2011

Top Cancer News Stories of 2011

(posted Dec 23rd, 2011)


Today's is the 40th anniversary of Pres. Nixon's War on Cancer (pbs, wsj).  It must be one of the longest running battles in the US history.  But, now Harold Varmus, Director of the National Cancer Institute, thinks that it is time to change the metaphor: Cancer is neither a single enemy nor a war (wsjblog).  While this "war" has consumed trillions of dollars and changed the face of cancer into a "chronic" and manageable condition, somehow, the word "cancer" did not make it to the top ten searched terms this year.  Google Zeitgeist (US) 2011  lists Steve Jobs and two of Apple's creations, iPhone5 and iPad2 among the top ten.  The rest is showbiz.  Just five years ago, "cancer" was number three on the Google News top searches (see here). 


For those who think about cancer, here are the top cancer news stories of the year 2011